BRINP1 antibody
Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
BRINP1 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab02253
tested applications
ELISA, WB, IHC
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | deleted in bladder cancer 1 (BRINP1) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | WB: 1:500-1:2000; IHC: 1:20-1:200 |
| Clonality | polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Observed MW | 88 kDa |
| Purity | ≥95% as determined by SDS-PAGE |
| Purification | Immunogen affinity purified |
| Size 1 | 100µg |
| Form | liquid |
| Tested Applications | ELISA, WB, IHC |
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| UniProt ID | O60477 |
| Alias | BMP/retinoic acid-inducible neural-specific protein 1,Deleted in bladder cancer protein 1,BRINP1,DBC1,DBCCR1,FAM5A |
| Background | Antibody anti-BRINP1 |
| Status | RUO |
| Note | Mol. Weight 88 kDa |
Related Products
BRINP1 antibody
Ver ProductoBRINP1 antibody
Ver Producto
BMP/Retinoic Acid Inducible Neural Specific 1 (BRINP1) Antibody
DBC1 is located within a chromosomal region that shows loss of heterozygosity in some bladder cancers. It contains a 5' CpG island that may be a frequent target of hypermethylation, and it may undergo hypermethylation-based silencing in some bladder cancers.
Ver Producto